Nuveen’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Nuveen’s Portfolio GEVA Stock Details GEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-26,158	Closed	-$2.55M	–	1697
2015 Q1	$2.55M	Sell	26,158 -1,228	-4%	-$130K	0.01%	738
2014 Q4	$2.54M	Buy	27,386 +6,729	+33%	+$531K	0.01%	753
2014 Q3	$1.42M	Buy	20,657 +2,485	+14%	+$178K	0.01%	970
2014 Q2	$1.91M	Buy	+18,172	New	+$1.55M	0.01%	838

Nuveen's GEVA Position: Q2 2015 in Review

Nuveen sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 26,158 shares — an estimated $2.55M sold.

Nuveen first reported a position in GEVA in Q2 2014 and held it in 4 quarters. The position peaked at $2.55M in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

Nuveen reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Nuveen sold 26,158 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $2.55M.
Nuveen first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q2 2014 and held it in 4 quarters.
Nuveen's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $2.55M in Q1 2015.
0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Nuveen's 13F filing for Q2 2015, filed 14 Aug 2015.